VR Adviser’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$80.8M Hold
2025
Q1
$79.2M Hold
2024
Q4
$90.6M Hold
2024
Q3
$103M Hold
2024
Q2
$94.1M Hold
2024
Q1
$70.8M Buy
2023
Q4
$40.9M Hold
2023
Q3
$40.4M Buy
2023
Q2
$45.5M Buy
2023
Q1
$48.5M Buy